Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Navin Saxena Research and Technology (NSRT) is a research-driven pharmaceutical enterprise and the R&D arm of Rusan Pharma. Established in 1994 with a state-of-the-art facility inaugurated in 2016 in the Kandla Special Economic Zone (KASEZ) in Gujarat, India, NSRT focuses on computer-aided drug design (CADD), active pharmaceutical ingredient (API) synthesis, and novel drug delivery systems (NDDS). The company specializes in niche therapeutic areas including addiction treatment, pain management, central nervous system (CNS) disorders, and orphan diseases. NSRT's platform technologies include transdermal patches, biodegradable implants, oral dispersible films, and nanotechnology. Additionally, NSRT offers contract research and development (CRO) and contract manufacturing services (CMO) for controlled substances and generic formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Navin Saxena Research and Technology.